Orakl Oncology
Developer of an artificial intelligence and biology-native platform designed to support cancer drug discovery and development. The company offers real-patient data integration and predictive modeling ...
Valuation
$0
Share Price
N/A
Total Raised
$14.9M
Last Round
N/A